Proteomic profiling of urine for the detection of colon cancer

Proteome Science

Volumn 6, Issue , 2008, Pages

  Ward, Douglas G ^a   Nyangoma, Stephen ^a   Joy, Howard ^a   Hamilton, Emma ^a   Wei, Wenbin ^a   Tselepis, Chris ^a   Steven, Neil ^a   Wakelam, Michael J O ^a   Johnson, Philip J ^a   Ismail, Tariq ^b   Martin, Ashley ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; FIBRINOGEN; HEPCIDIN; PROTEIN; SYNTHETIC PEPTIDE;

AGED; ARTICLE; CANCER DIAGNOSIS; COLORECTAL CANCER; CONFOUNDING VARIABLE; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL PROTEOMICS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS;

EID: 46649111008     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-6-19     Document Type: Article

References (40)

1. Hewitson P Glasziou P Irwig L Towler B Watson E Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Systematic Reviews 2007, 1-25
2. Moshkowitz M Arber N Emerging technologies in colorectal cancer screening. Surg Oncol Clin N Am 2005, 14(4):723-746 10.1016/ j.soc.2005.05.010 16226688
3. Hurst NG Stocken DD Wilson S Keh C Wakelam MJO Ismail T Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients Br J Cancer 2007, 97:971-977 10.1038/sj.bjc.6603958 17912241
4. Habermann JK Roblick UJ Luke BT Prieto DA Finlay WJ Podust VN Roman JM Oevermann E Schiedeck T Homann N Duchrow M Conrads TP Veenstra TD Burt SK Bruch HP Auer G Ried T Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors. Gastroenterology 2006, 131(4):1020-1029 10.1053/j.gastro.2006.07.011 17030172
5. Melle C Ernst G Schimmel B Bleul A Thieme H Kaufmann R Mothes H Settmacher U Claussen U Halbhuber KJ Von Eggeling F Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology 2005, 129(1);66-73 10.1053/j.gastro.2005.05.014 16012935
6. Ward DG Suggett N Cheng Y Wei W Johnson H Billingham LJ Ismail T Wakelam MJO Johnson PJ Martin A Identification of serum biomarkers for colon cancer by proteomic analysis British Journal of Cancer 2006, 94(12):1898-1905 10.1038/sj.bjc.6603188 16755300
7. Diamandis EP Van der Merwe DE Plasma protein profiling by mass spectrometry for cancer diagnosis: Opportunities and limitations. Clinical Cancer Research 2005, 11:963-965 15709159
8. Engwegen JY Gast MC Schellens JH Beijnen JH Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci 2006, 27(5):251-259 10.1016/j.tips.2006.03.003 16600386
9. Kennedy S Proteomic profiling from human samples: The body fluid alternative Toxicology Letters 2001, 120:379-384 10.1016/ S0378-4274(01)00269-7 11323197
10. Villanueva J Philip J Entenberg D Chaparro CA Tanwar MK Holland EC Tempst P Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. 2004, 76(6):1560-1570 15018552
11. Petricoin EF Ardekani AM Hitt BA Levine PJ Fusaro VA Steinberg SM Mills GB Simone C Fishman DA Kohn EC Liotta LA Use of proteomic patterns in serum to identiy ovarian cancer. Lancet 2002, 359:572-575 10.1016/ S0140-6736(02)07746-2 11867112
12. Ransohoff DF Rules of evidence for cancer molecular-marker discovery and validation Nature Reviews: Cancer 2004, 4:309-313 10.1038/nrc1322 15057290
13. Albrethsen J Bogebo R Gammeltoft S Olsen J Winther B Raskov H Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: A biomarker study. BMC Cancer 2005, 19(5):8 10.1186/1471-2407-5-8
14. Chen Y Zheng S Yu JK Hu X Artificial neural networks analysis of surface-enhanced laser desorbtion/ionisation mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clinical Cancer Research 2004, 10:8380-8385 10.1158/ 1078-0432.CCR-1162-03 15623616
15. Engwegen JY Helgason HH Cats A Harris N Bonfrer JM Schellens JH Beijnen JH Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry World Journal of Gastroenterology 2006, 12(10):1536-1544 16570345
16. Seraglia R Ragazzi E Vogliardi S Allegri G Pucciarelli S Agastoni M Lise M Nitti D Urso ED Traldi P Search for plasma biomarkers for colorectal cancer by matrix-assisted laser desorption/ionization mass spectrometry Journal of Mass Spectrometry 2004
17. Yu JK Chen YD Zheng S An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics World Journal of Gastroenterology 2004, 10(21):3127-3131 15457557
18. Atkinson JM Pennington CJ Martin SW Anikin VA Mearns AJ Loadman PM Edwards DR Gill JH Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: Correlation of MMP-14 mRNA expression and proteolytic activity. European Journal of Cancer 2007 17600697
19. Mook OR Frederiks WM Van Noorden CJ The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 2004, 1705(2):69-89 15588763
20. M'Koma AE Blum DL Norris JL Koyama T Billheimer D Motley S Ghiassi M Ferdowsi N Bhowmick I Chang SS Fowke JH Caprioli RM Bhowmick NA Detection of pre-neoplastic and neoplastic prostate disease by MALDI profiling of urine. Biochem Biophys Res Commun 2007, 353(3):829-834 10.1016/j.bbrc.2006.12.111 17194448
21. Munro NP Cairns DA Clarke P Rogers M Stanley AJ Barrett JH Harnden P Thompson D Eardley I Banks RE Knowles MA Urinary biomarker profiling in transitional cell carcinoma Int J Cancer 2006, 116(11):2642-2650 10.1002/ ijc.22238
22. Roelofsen H Alvarez-Llamas G Schepers M Landman K Vonk RJ Proteomics profiling of urine with surface enhanced laser desorption/ionization time of flight mass spectrometry Proteome Science 2007, 5:2 1783644 17224053
23. Rogers MA Clarke P Noble J Munro NP Paul A Selby PJ Banks RE Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: Identification of key issues affecting potential clinical utility. Cancer Research 2003, 63(20):6971-6983 14583499
24. Schaub S Wilkins J Weiler T Sangster K Rush D Nickerson P Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry Kidney International 2004, 65(1):323-332 10.1111/j.1523-1755.2004.00352.x 14675066
25. Vlahou A Schellhammer PF Mendrinos S Patel K Kondylis FI Gong L Nasim S Wright GLJ Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. American Journal of Pathology 2001, 158:1491-1502 1891900 11290567
26. Zhang YF Wu DL Guan M Liu WW Wu Z Chen YM Zhang WZ Lu Y Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient. Clin Biochem 2004, 37(9):772-779 10.1016/j.clinbiochem.2004.04.002 15329315
27. Ye B Skates S Mok SC Horick NK Rosenberg HF Vitonis A Edwards D Sluss P Han WK Berkowitz RS Cramer DW Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clinical Cancer Research 2006, 12(2):432-441 10.1158/ 1078-0432.CCR-05-0461 16428483
28. Ward DG Chen YC N'Kontchou G Thar TT Barget N Wei W Billingham LJ Martin A Beaugrand M Johnson PJ HCC induced changes in the serum proteome of hepatitis C infected chronic liver disease patients British Journal of Cancer 2006, 94(2):287-292 10.1038/sj.bjc.6602923 16404431
29. Ihaka R Gentleman R R: A language for data analysis and graphics Journal of computational and graphical statistics 1996, 5:299-314 10.2307/1390807
30. Ward DG Cheng Y N'Kontchou GN Thar TT Barget N Wei W Martin A Beaugrand M Johnson PJ Preclinical and post-treatment changes in the HCC-associated serum proteome British Journal of Cancer 2006, 95:1379-1383 10.1038/sj.bjc.6603429 17060939
31. Kemna E Tjalsma H Laarakkers C Nemeth E Willems H Swinkels D Novel urine hepcidin assay by mass spectrometry. Blood 2005, 106(9):3268-3270 10.1182/blood-2005-05-1873 16030189
32. Hunter HN Fulton DB Ganz T Vogel HJ The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 2002, 277(40):37597-37603 10.1074/jbc.M205305200 12138110
33. Lauth X Babon JJ Stannard JA Singh S Nizet V Carlberg JM Ostland VE Pennington MW Norton RS Westerman ME Bass hepcidin synthesis, solution structure, antimicrobial activities and synergism, and in vivo hepatic response to bacterial infections. J Biol Chem 2005, 280(10):9272-9282 10.1074/jbc.M411154200 15546886
34. Nemeth E Valore EV Territo M Schiller G Lichtenstein A Ganz T Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003 101(7) 12433676
35. Brookes MJ Hughes S Turner FE Reynolds G Sharma N Ismail T Berx G McKie AT Hotchin N Anderson GJ Iqbal T Tselepis C Modulation of iron transport proteins in human colorectal carcinogenesis Gut 2006, 55(10):1449-1460 10.1136/gut.2006.094060 16641131
36. Ward DG Roberts K Brookes MJ Joy H Martin A Ismail T Spychal R Iqbal T Tselepis C Increased hepcidin expression in colorectal carcinogenesis World J Gastroenterol 2007, 14(9):1339-1345 10.3748/wjg.14.1339
37. Cooper EH Plesner T Beta-2-microglobulin review: Its relevance in clinical oncology. Med Pediatr Oncol 1980, 8(4):323-334 10.1002/ mpo.2950080403 6161299
38. Shi Q Harris LN Lu X Li X Hwang J Gentleman R Iglehart JD Miron A Declining plasma fibrinogen alpha fragment identifies HER2-positive breast cancer patients and reverts to normal levels after surgery. Journal of Proteome Research 2006, 5:2947-2955 10.1021/pr060099u 17081046
39. Villanueva J Shaffer DR Philip J Chaparro CA Erdjument-Bromage H Olshen AB Fleisher M Lilja H Brogi E Boyd J Sanchez-Carbayo M Holland EC Cordon-Cardo C Scher HI Tempst P Differential exoprotease activities confer tumor-specific serum peptidome patterns J Clin Invest 2006, 116(1):271-284 1323259 16395409 10.1172/JCI26022
40. CoaBattistelli S Stefanoni M Lorenzi B Dell'avanzato R Varrone F Pascucci A Petrioli R Vittoria A Coagulation factor levels in non-metastatic colorectal cancer patients. International Journal of Biological Markers 2008, 23(1):36-41 18409149